comparemela.com

Latest Breaking News On - Analyst rahul sarugaser - Page 1 : comparemela.com

Fusion Pharmaceuticals is a triple, says Raymond James – Cantech Letter

Raymond James analyst Rahul Sarugaser initiated coverage with an “Outperform” rating on Friday on Fusion Pharmaceuticals.

United statesNovarti pluvictoRahul sarugaserNovarti lutatheraBayer xofigoFusion pharmaceuticals stockFusion pharmaceuticalsFusion pharmaceuticals stock quoteRaymond jamesAnalyst rahul sarugaser

Medexus gets a target increase from Raymond James

Québec-based specialty pharma company Medexus Pharmaceuticals received a target price increase from Raymond James on Thursday after securing a new bank debt.

Rahul sarugaserMarcel konradMedexus pharmaceuticals stockMedexus pharmaceuticalsMedexus pharmaceuticals stock quoteRaymond jamesAnalyst rahul sarugaser

vimarsana © 2020. All Rights Reserved.